US Stock MarketDetailed Quotes

XENE Xenon Pharmaceuticals

Watchlist
  • 35.790
  • -1.230-3.32%
Close Mar 3 16:00 ET
  • 35.790
  • 0.0000.00%
Post 16:05 ET
2.74BMarket Cap-11.89P/E (TTM)

Xenon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-20.04%-181.39M
-53.63%-54.39M
-6.38%-51.15M
1.63%-32.68M
-25.48%-43.18M
-49.57%-151.11M
-0.20%-35.4M
-58.14%-48.08M
-96.95%-33.22M
-86.73%-34.41M
Net income from continuing operations
-28.48%-234.33M
-46.81%-65.69M
-29.57%-62.79M
-22.05%-57.92M
-14.87%-47.93M
-45.48%-182.39M
-19.65%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-112.14%-41.73M
Operating gains losses
216.41%745K
398.23%563K
121.26%64K
125.50%114K
180.00%4K
-123.45%-640K
115.59%113K
-110.16%-301K
-170.50%-447K
96.48%-5K
Depreciation and amortization
24.21%2.56M
200.64%633K
-61.42%669K
9.47%659K
69.21%599K
46.69%2.06M
-312.50%-629K
384.36%1.73M
60.53%602K
-5.85%354K
Deferred tax
-2,935.62%-8.86M
-4,206.00%-8.61M
-106.41%-322K
-48.66%-333K
39.93%403K
-563.64%-292K
-4,100.00%-200K
23.15%-156K
-115.38%-224K
11.63%288K
Other non cash items
3.38%1.25M
----
----
----
----
48.11%1.21M
----
----
----
----
Change In working capital
-3.20%5.71M
958.04%2.19M
72.38%-911K
46.39%10.09M
-320.56%-5.65M
562.54%5.9M
-154.72%-255K
-37.13%-3.3M
0.04%6.89M
141.17%2.56M
-Change in receivables
-572.31%-614K
-86.05%-547K
-153.55%-83K
-151.16%-22K
-83.19%38K
-92.60%130K
-119.41%-294K
2,114.29%155K
-88.97%43K
245.81%226K
-Change in prepaid assets
-162.52%-984K
11.86%-2.23M
1,100.00%960K
-24.45%958K
-122.96%-673K
115.00%1.57M
60.89%-2.53M
97.85%-96K
78.34%1.27M
1,177.57%2.93M
-Change in payables and accrued expense
117.02%8.53M
168.75%6.18M
46.74%-1.79M
64.00%9.15M
-744.78%-5.02M
-51.24%3.93M
-61.76%2.3M
-263.36%-3.36M
-3.58%5.58M
89.76%-594K
-Change in other current liabilities
-556.93%-1.22M
----
----
----
----
144.50%267K
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-20.04%-181.39M
-53.63%-54.39M
-6.38%-51.15M
1.63%-32.68M
-25.48%-43.18M
-49.57%-151.11M
-0.20%-35.4M
-58.14%-48.08M
-96.95%-33.22M
-86.73%-34.41M
Investing cash flow
Cash flow from continuing investing activities
248.13%165M
141.08%98.5M
-96.33%1.98M
296.81%110.72M
-199.10%-46.2M
62.04%-111.39M
-1,943.03%-239.79M
123.02%53.88M
2,018.60%27.9M
195.36%46.62M
Net PPE purchase and sale
45.26%-3.08M
-903.85%-783K
50.83%-590K
29.02%-1.51M
91.48%-188K
-94.09%-5.62M
95.55%-78K
-210.88%-1.2M
-292.10%-2.13M
-940.57%-2.21M
Net investment purchase and sale
258.91%168.08M
141.42%99.29M
-95.33%2.57M
273.67%112.23M
-194.24%-46.01M
63.59%-105.77M
-2,300.72%-239.71M
123.57%55.08M
1,513.92%30.04M
200.31%48.83M
Cash from discontinued investing activities
Investing cash flow
248.13%165M
141.08%98.5M
-96.33%1.98M
296.81%110.72M
-199.10%-46.2M
62.04%-111.39M
-1,943.03%-239.79M
123.02%53.88M
2,018.60%27.9M
195.36%46.62M
Financing cash flow
Cash flow from continuing financing activities
-96.57%12.13M
-96.26%12.13M
26.95%353.52M
5,400,133.33%324.01M
Net common stock issuance
-96.58%12.08M
-96.27%12.08M
----
----
----
27.26%353.49M
--323.98M
----
----
----
Proceeds from stock option exercised by employees
34.29%47K
----
----
----
----
-95.04%35K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-96.57%12.13M
-96.26%12.13M
----
----
----
26.95%353.52M
5,400,133.33%324.01M
----
----
----
Net cash flow
Beginning cash position
159.67%148.64M
-12.00%87.62M
111.82%136.73M
-15.27%58.9M
159.67%148.64M
-67.42%57.24M
-3.78%99.57M
-82.55%64.55M
-40.35%69.51M
-67.42%57.24M
Current changes in cash
-104.68%-4.26M
15.21%56.25M
-239.24%-49.17M
1,567.19%78.04M
-831.96%-89.38M
178.50%91.03M
203.74%48.82M
113.39%35.31M
-102.09%-5.32M
120.54%12.21M
Effect of exchange rate changes
-544.68%-1.67M
-570.33%-1.16M
118.75%54K
-156.27%-202K
-722.03%-367K
115.14%376K
-69.78%246K
89.33%-288K
140.20%359K
-79.86%59K
End cash Position
-3.99%142.71M
-3.99%142.71M
-12.00%87.62M
111.82%136.73M
-15.27%58.9M
159.67%148.64M
159.67%148.64M
-3.78%99.57M
-82.55%64.55M
-40.35%69.51M
Free cash flow
-17.70%-184.46M
-55.49%-55.17M
-4.99%-51.74M
3.28%-34.19M
-18.43%-43.37M
-50.81%-156.73M
4.32%-35.48M
-60.06%-49.28M
-103.04%-35.35M
-96.44%-36.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -20.04%-181.39M-53.63%-54.39M-6.38%-51.15M1.63%-32.68M-25.48%-43.18M-49.57%-151.11M-0.20%-35.4M-58.14%-48.08M-96.95%-33.22M-86.73%-34.41M
Net income from continuing operations -28.48%-234.33M-46.81%-65.69M-29.57%-62.79M-22.05%-57.92M-14.87%-47.93M-45.48%-182.39M-19.65%-44.74M-30.45%-48.46M-52.32%-47.46M-112.14%-41.73M
Operating gains losses 216.41%745K398.23%563K121.26%64K125.50%114K180.00%4K-123.45%-640K115.59%113K-110.16%-301K-170.50%-447K96.48%-5K
Depreciation and amortization 24.21%2.56M200.64%633K-61.42%669K9.47%659K69.21%599K46.69%2.06M-312.50%-629K384.36%1.73M60.53%602K-5.85%354K
Deferred tax -2,935.62%-8.86M-4,206.00%-8.61M-106.41%-322K-48.66%-333K39.93%403K-563.64%-292K-4,100.00%-200K23.15%-156K-115.38%-224K11.63%288K
Other non cash items 3.38%1.25M----------------48.11%1.21M----------------
Change In working capital -3.20%5.71M958.04%2.19M72.38%-911K46.39%10.09M-320.56%-5.65M562.54%5.9M-154.72%-255K-37.13%-3.3M0.04%6.89M141.17%2.56M
-Change in receivables -572.31%-614K-86.05%-547K-153.55%-83K-151.16%-22K-83.19%38K-92.60%130K-119.41%-294K2,114.29%155K-88.97%43K245.81%226K
-Change in prepaid assets -162.52%-984K11.86%-2.23M1,100.00%960K-24.45%958K-122.96%-673K115.00%1.57M60.89%-2.53M97.85%-96K78.34%1.27M1,177.57%2.93M
-Change in payables and accrued expense 117.02%8.53M168.75%6.18M46.74%-1.79M64.00%9.15M-744.78%-5.02M-51.24%3.93M-61.76%2.3M-263.36%-3.36M-3.58%5.58M89.76%-594K
-Change in other current liabilities -556.93%-1.22M----------------144.50%267K----------------
Cash from discontinued investing activities
Operating cash flow -20.04%-181.39M-53.63%-54.39M-6.38%-51.15M1.63%-32.68M-25.48%-43.18M-49.57%-151.11M-0.20%-35.4M-58.14%-48.08M-96.95%-33.22M-86.73%-34.41M
Investing cash flow
Cash flow from continuing investing activities 248.13%165M141.08%98.5M-96.33%1.98M296.81%110.72M-199.10%-46.2M62.04%-111.39M-1,943.03%-239.79M123.02%53.88M2,018.60%27.9M195.36%46.62M
Net PPE purchase and sale 45.26%-3.08M-903.85%-783K50.83%-590K29.02%-1.51M91.48%-188K-94.09%-5.62M95.55%-78K-210.88%-1.2M-292.10%-2.13M-940.57%-2.21M
Net investment purchase and sale 258.91%168.08M141.42%99.29M-95.33%2.57M273.67%112.23M-194.24%-46.01M63.59%-105.77M-2,300.72%-239.71M123.57%55.08M1,513.92%30.04M200.31%48.83M
Cash from discontinued investing activities
Investing cash flow 248.13%165M141.08%98.5M-96.33%1.98M296.81%110.72M-199.10%-46.2M62.04%-111.39M-1,943.03%-239.79M123.02%53.88M2,018.60%27.9M195.36%46.62M
Financing cash flow
Cash flow from continuing financing activities -96.57%12.13M-96.26%12.13M26.95%353.52M5,400,133.33%324.01M
Net common stock issuance -96.58%12.08M-96.27%12.08M------------27.26%353.49M--323.98M------------
Proceeds from stock option exercised by employees 34.29%47K-----------------95.04%35K----------------
Cash from discontinued financing activities
Financing cash flow -96.57%12.13M-96.26%12.13M------------26.95%353.52M5,400,133.33%324.01M------------
Net cash flow
Beginning cash position 159.67%148.64M-12.00%87.62M111.82%136.73M-15.27%58.9M159.67%148.64M-67.42%57.24M-3.78%99.57M-82.55%64.55M-40.35%69.51M-67.42%57.24M
Current changes in cash -104.68%-4.26M15.21%56.25M-239.24%-49.17M1,567.19%78.04M-831.96%-89.38M178.50%91.03M203.74%48.82M113.39%35.31M-102.09%-5.32M120.54%12.21M
Effect of exchange rate changes -544.68%-1.67M-570.33%-1.16M118.75%54K-156.27%-202K-722.03%-367K115.14%376K-69.78%246K89.33%-288K140.20%359K-79.86%59K
End cash Position -3.99%142.71M-3.99%142.71M-12.00%87.62M111.82%136.73M-15.27%58.9M159.67%148.64M159.67%148.64M-3.78%99.57M-82.55%64.55M-40.35%69.51M
Free cash flow -17.70%-184.46M-55.49%-55.17M-4.99%-51.74M3.28%-34.19M-18.43%-43.37M-50.81%-156.73M4.32%-35.48M-60.06%-49.28M-103.04%-35.35M-96.44%-36.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Jiangsu Changyou Environmental Protection Technology
301557
+253.98%
Hefei conver Holding
603409
+145.24%
CHK
831167
+29.97%
4
HAOMIAO TECHNOLOGY
831856
+29.95%
5
HENGHE CO.,LTD.
832145
+29.94%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Earnings Season Underway
Earnings season is here. What to know?
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More
TSLA earnings preview: Grab rewards by guessing the opening price!